Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs
Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2022-06-07. On CanQuery you can follow the original downloads. Files are available in English and French.
This guidance document applies to all biologic drug submissions where the sponsor seeks authorization for sale based on demonstrated similarity to a previously approved biologic drug and relies, in part, on prior information regarding that biologic drug in order to present a reduced clinical and non-clinical package as part of the submission.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2022-06-07
Data overview
- Formats
- HTML
- File languages
- English, French